CLINICAL STUDY REPORTING
PHASTAR has a unique approach to the analysis and reporting of clinical trials. All our staff are trained in "The PHASTAR Discipline" - our in-house philosophy relating to the methodology of clinical trial data analysis and reporting.
PHASTAR has experience in all therapeutic areas, including:
|
|
|
We cover all phases including the following types of studies:
|
|
|
Our services include:
|
|
|
CDISC
PHASTAR's Programming team provide expert CDISC services as well as the development of dataset specifications. If you have a submission approaching with legacy format datasets, PHASTAR can upgrade these to CDISC compliant datasets (SDTM and ADaM). PHASTAR’s senior team has extensive experience with regulatory bodies and participate in regular regulatory interactions.
We can provide all the necessary associated documentation that a submission to the FDA will require (or other global regulators), including annotated CRFs, define.xml and/or define.pdf and a regulatory reviewer's guide. If you are planning an integrated summary of efficacy and safety, we can help put together CDISC compliant datasets. We can also provide advice on the format of the data that will be acceptable to global regulatory bodies.
What our clients say

Big Pharma Company

Mid-Size Biotech Company

Top 20 Pharma Company

Top 10 Pharma Company

Top 10 Pharma Company

Large Pharma Company

Top 10 Pharma Company

Top 10 Pharma Company

Top 10 Pharma Company

Top 10 Pharma Company
Interested? Click on the button to see our Case Studies